Stay updated on TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 is added to the version history, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:22.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Results and related sections have been posted (Results, Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Study Status), and the prior 'Results Submitted' entry has been removed.
    Difference
    0.6%
    Check dated 2026-02-18T16:47:43.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 was added to the history; notices about government funding lapse and the Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T11:15:05.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The study record history updates to show Results Submitted and Revision: v3.4.1, replacing the previous No Results Posted status; a site-wide government funding notice was also added.
    Difference
    0.5%
    Check dated 2026-02-04T06:36:37.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page now includes a Show glossary option and color-coded additions (green) and deletions (red); the revision footer updated to v3.4.0, and the No FEAR Act Data label wording was adjusted.
    Difference
    0.5%
    Check dated 2026-01-28T04:26:35.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    Added a new 'Study Status' entry to the version history (latest version v57 dated 2026-01-16) reflecting the current recruitment/activation status.
    Difference
    0.2%
    Check dated 2026-01-21T02:43:02.000Z thumbnail image

Stay in the know with updates to TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.